世界の急性反復発作(ARS)市場規模・現状・予測2021-2027

【英語タイトル】Global Acute Repetitive Seizures Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0078)・商品コード:QY21APR0078
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:96
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、急性反復発作(ARS)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(USL-261、NRL-1、AZ-002、ダイアスタットレクタルジェル、その他)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性反復発作(ARS)の市場動向
・企業の競争状況、市場シェア
・急性反復発作(ARS)の種類別市場規模(USL-261、NRL-1、AZ-002、ダイアスタットレクタルジェル、その他)
・急性反復発作(ARS)の用途別市場規模(病院、クリニック)
・急性反復発作(ARS)の北米市場規模2016-2027(アメリカ、カナダ)
・急性反復発作(ARS)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性反復発作(ARS)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性反復発作(ARS)の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性反復発作(ARS)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(UCB S.A.、Neurelis、Valeant Pharmaceuticals North America LLC.、Alexza Pharmaceuticals、Veriton Pharma)
・結論
【レポートの概要】

Based on product, the market is categorized into USL-261, NRL-1, AZ-002, Diastat Rectal Gel {DRG.

Market Analysis and Insights: Global Acute Repetitive Seizures Market
The global Acute Repetitive Seizures market size is projected to reach US$ 1748.2 million by 2026, from US$ 174.4 million in 2019, at a CAGR of 38.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Repetitive Seizures market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Repetitive Seizures market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Repetitive Seizures market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Repetitive Seizures market.

Global Acute Repetitive Seizures Scope and Market Size
Acute Repetitive Seizures market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Repetitive Seizures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
USL-261
NRL-1
AZ-002
Diastat Rectal Gel
Others

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
UCB S.A.
Neurelis
Valeant Pharmaceuticals North America LLC.
Alexza Pharmaceuticals
Veriton Pharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Repetitive Seizures Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 USL-261
1.2.3 NRL-1
1.2.4 AZ-002
1.2.5 Diastat Rectal Gel
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Repetitive Seizures Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Repetitive Seizures Market Perspective (2016-2027)
2.2 Acute Repetitive Seizures Growth Trends by Regions
2.2.1 Acute Repetitive Seizures Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Repetitive Seizures Historic Market Share by Regions (2016-2021)
2.2.3 Acute Repetitive Seizures Forecasted Market Size by Regions (2022-2027)
2.3 Acute Repetitive Seizures Industry Dynamic
2.3.1 Acute Repetitive Seizures Market Trends
2.3.2 Acute Repetitive Seizures Market Drivers
2.3.3 Acute Repetitive Seizures Market Challenges
2.3.4 Acute Repetitive Seizures Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Repetitive Seizures Players by Revenue
3.1.1 Global Top Acute Repetitive Seizures Players by Revenue (2016-2021)
3.1.2 Global Acute Repetitive Seizures Revenue Market Share by Players (2016-2021)
3.2 Global Acute Repetitive Seizures Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Repetitive Seizures Revenue
3.4 Global Acute Repetitive Seizures Market Concentration Ratio
3.4.1 Global Acute Repetitive Seizures Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Repetitive Seizures Revenue in 2020
3.5 Acute Repetitive Seizures Key Players Head office and Area Served
3.6 Key Players Acute Repetitive Seizures Product Solution and Service
3.7 Date of Enter into Acute Repetitive Seizures Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Repetitive Seizures Breakdown Data by Type
4.1 Global Acute Repetitive Seizures Historic Market Size by Type (2016-2021)
4.2 Global Acute Repetitive Seizures Forecasted Market Size by Type (2022-2027)

5 Acute Repetitive Seizures Breakdown Data by Application
5.1 Global Acute Repetitive Seizures Historic Market Size by Application (2016-2021)
5.2 Global Acute Repetitive Seizures Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Repetitive Seizures Market Size (2016-2027)
6.2 North America Acute Repetitive Seizures Market Size by Type
6.2.1 North America Acute Repetitive Seizures Market Size by Type (2016-2021)
6.2.2 North America Acute Repetitive Seizures Market Size by Type (2022-2027)
6.2.3 North America Acute Repetitive Seizures Market Size by Type (2016-2027)
6.3 North America Acute Repetitive Seizures Market Size by Application
6.3.1 North America Acute Repetitive Seizures Market Size by Application (2016-2021)
6.3.2 North America Acute Repetitive Seizures Market Size by Application (2022-2027)
6.3.3 North America Acute Repetitive Seizures Market Size by Application (2016-2027)
6.4 North America Acute Repetitive Seizures Market Size by Country
6.4.1 North America Acute Repetitive Seizures Market Size by Country (2016-2021)
6.4.2 North America Acute Repetitive Seizures Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Repetitive Seizures Market Size (2016-2027)
7.2 Europe Acute Repetitive Seizures Market Size by Type
7.2.1 Europe Acute Repetitive Seizures Market Size by Type (2016-2021)
7.2.2 Europe Acute Repetitive Seizures Market Size by Type (2022-2027)
7.2.3 Europe Acute Repetitive Seizures Market Size by Type (2016-2027)
7.3 Europe Acute Repetitive Seizures Market Size by Application
7.3.1 Europe Acute Repetitive Seizures Market Size by Application (2016-2021)
7.3.2 Europe Acute Repetitive Seizures Market Size by Application (2022-2027)
7.3.3 Europe Acute Repetitive Seizures Market Size by Application (2016-2027)
7.4 Europe Acute Repetitive Seizures Market Size by Country
7.4.1 Europe Acute Repetitive Seizures Market Size by Country (2016-2021)
7.4.2 Europe Acute Repetitive Seizures Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Repetitive Seizures Market Size (2016-2027)
8.2 Asia-Pacific Acute Repetitive Seizures Market Size by Type
8.2.1 Asia-Pacific Acute Repetitive Seizures Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Repetitive Seizures Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Repetitive Seizures Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Repetitive Seizures Market Size by Application
8.3.1 Asia-Pacific Acute Repetitive Seizures Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Repetitive Seizures Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Repetitive Seizures Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Repetitive Seizures Market Size by Region
8.4.1 Asia-Pacific Acute Repetitive Seizures Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Repetitive Seizures Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Repetitive Seizures Market Size (2016-2027)
9.2 Latin America Acute Repetitive Seizures Market Size by Type
9.2.1 Latin America Acute Repetitive Seizures Market Size by Type (2016-2021)
9.2.2 Latin America Acute Repetitive Seizures Market Size by Type (2022-2027)
9.2.3 Latin America Acute Repetitive Seizures Market Size by Type (2016-2027)
9.3 Latin America Acute Repetitive Seizures Market Size by Application
9.3.1 Latin America Acute Repetitive Seizures Market Size by Application (2016-2021)
9.3.2 Latin America Acute Repetitive Seizures Market Size by Application (2022-2027)
9.3.3 Latin America Acute Repetitive Seizures Market Size by Application (2016-2027)
9.4 Latin America Acute Repetitive Seizures Market Size by Country
9.4.1 Latin America Acute Repetitive Seizures Market Size by Country (2016-2021)
9.4.2 Latin America Acute Repetitive Seizures Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Repetitive Seizures Market Size (2016-2027)
10.2 Middle East & Africa Acute Repetitive Seizures Market Size by Type
10.2.1 Middle East & Africa Acute Repetitive Seizures Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Repetitive Seizures Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Repetitive Seizures Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Repetitive Seizures Market Size by Application
10.3.1 Middle East & Africa Acute Repetitive Seizures Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Repetitive Seizures Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Repetitive Seizures Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Repetitive Seizures Market Size by Country
10.4.1 Middle East & Africa Acute Repetitive Seizures Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Repetitive Seizures Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 UCB S.A.
11.1.1 UCB S.A. Company Details
11.1.2 UCB S.A. Business Overview
11.1.3 UCB S.A. Acute Repetitive Seizures Introduction
11.1.4 UCB S.A. Revenue in Acute Repetitive Seizures Business (2016-2021)
11.1.5 UCB S.A. Recent Development
11.2 Neurelis
11.2.1 Neurelis Company Details
11.2.2 Neurelis Business Overview
11.2.3 Neurelis Acute Repetitive Seizures Introduction
11.2.4 Neurelis Revenue in Acute Repetitive Seizures Business (2016-2021)
11.2.5 Neurelis Recent Development
11.3 Valeant Pharmaceuticals North America LLC.
11.3.1 Valeant Pharmaceuticals North America LLC. Company Details
11.3.2 Valeant Pharmaceuticals North America LLC. Business Overview
11.3.3 Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Introduction
11.3.4 Valeant Pharmaceuticals North America LLC. Revenue in Acute Repetitive Seizures Business (2016-2021)
11.3.5 Valeant Pharmaceuticals North America LLC. Recent Development
11.4 Alexza Pharmaceuticals
11.4.1 Alexza Pharmaceuticals Company Details
11.4.2 Alexza Pharmaceuticals Business Overview
11.4.3 Alexza Pharmaceuticals Acute Repetitive Seizures Introduction
11.4.4 Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Business (2016-2021)
11.4.5 Alexza Pharmaceuticals Recent Development
11.5 Veriton Pharma
11.5.1 Veriton Pharma Company Details
11.5.2 Veriton Pharma Business Overview
11.5.3 Veriton Pharma Acute Repetitive Seizures Introduction
11.5.4 Veriton Pharma Revenue in Acute Repetitive Seizures Business (2016-2021)
11.5.5 Veriton Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Repetitive Seizures Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of USL-261
Table 3. Key Players of NRL-1
Table 4. Key Players of AZ-002
Table 5. Key Players of Diastat Rectal Gel
Table 6. Key Players of Others
Table 7. Global Acute Repetitive Seizures Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Repetitive Seizures Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Acute Repetitive Seizures Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Acute Repetitive Seizures Market Share by Regions (2016-2021)
Table 11. Global Acute Repetitive Seizures Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Acute Repetitive Seizures Market Share by Regions (2022-2027)
Table 13. Acute Repetitive Seizures Market Trends
Table 14. Acute Repetitive Seizures Market Drivers
Table 15. Acute Repetitive Seizures Market Challenges
Table 16. Acute Repetitive Seizures Market Restraints
Table 17. Global Acute Repetitive Seizures Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Acute Repetitive Seizures Market Share by Players (2016-2021)
Table 19. Global Top Acute Repetitive Seizures Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures as of 2020)
Table 20. Ranking of Global Top Acute Repetitive Seizures Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Acute Repetitive Seizures Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Repetitive Seizures Product Solution and Service
Table 24. Date of Enter into Acute Repetitive Seizures Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Acute Repetitive Seizures Revenue Market Share by Type (2016-2021)
Table 28. Global Acute Repetitive Seizures Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Acute Repetitive Seizures Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Acute Repetitive Seizures Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Acute Repetitive Seizures Revenue Market Share by Application (2016-2021)
Table 32. Global Acute Repetitive Seizures Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Acute Repetitive Seizures Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Acute Repetitive Seizures Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Acute Repetitive Seizures Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Acute Repetitive Seizures Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Acute Repetitive Seizures Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Acute Repetitive Seizures Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Acute Repetitive Seizures Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Acute Repetitive Seizures Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Acute Repetitive Seizures Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Acute Repetitive Seizures Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Acute Repetitive Seizures Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Repetitive Seizures Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Repetitive Seizures Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Repetitive Seizures Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Repetitive Seizures Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Acute Repetitive Seizures Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Acute Repetitive Seizures Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Acute Repetitive Seizures Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Acute Repetitive Seizures Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Acute Repetitive Seizures Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Acute Repetitive Seizures Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Repetitive Seizures Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Repetitive Seizures Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Repetitive Seizures Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Repetitive Seizures Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Repetitive Seizures Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Acute Repetitive Seizures Market Size by Country (2022-2027) & (US$ Million)
Table 64. UCB S.A. Company Details
Table 65. UCB S.A. Business Overview
Table 66. UCB S.A. Acute Repetitive Seizures Product
Table 67. UCB S.A. Revenue in Acute Repetitive Seizures Business (2016-2021) & (US$ Million)
Table 68. UCB S.A. Recent Development
Table 69. Neurelis Company Details
Table 70. Neurelis Business Overview
Table 71. Neurelis Acute Repetitive Seizures Product
Table 72. Neurelis Revenue in Acute Repetitive Seizures Business (2016-2021) & (US$ Million)
Table 73. Neurelis Recent Development
Table 74. Valeant Pharmaceuticals North America LLC. Company Details
Table 75. Valeant Pharmaceuticals North America LLC. Business Overview
Table 76. Valeant Pharmaceuticals North America LLC. Acute Repetitive Seizures Product
Table 77. Valeant Pharmaceuticals North America LLC. Revenue in Acute Repetitive Seizures Business (2016-2021) & (US$ Million)
Table 78. Valeant Pharmaceuticals North America LLC. Recent Development
Table 79. Alexza Pharmaceuticals Company Details
Table 80. Alexza Pharmaceuticals Business Overview
Table 81. Alexza Pharmaceuticals Acute Repetitive Seizures Product
Table 82. Alexza Pharmaceuticals Revenue in Acute Repetitive Seizures Business (2016-2021) & (US$ Million)
Table 83. Alexza Pharmaceuticals Recent Development
Table 84. Veriton Pharma Company Details
Table 85. Veriton Pharma Business Overview
Table 86. Veriton Pharma Acute Repetitive Seizures Product
Table 87. Veriton Pharma Revenue in Acute Repetitive Seizures Business (2016-2021) & (US$ Million)
Table 88. Veriton Pharma Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Repetitive Seizures Market Share by Type: 2020 VS 2027
Figure 2. USL-261 Features
Figure 3. NRL-1 Features
Figure 4. AZ-002 Features
Figure 5. Diastat Rectal Gel Features
Figure 6. Others Features
Figure 7. Global Acute Repetitive Seizures Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Acute Repetitive Seizures Report Years Considered
Figure 11. Global Acute Repetitive Seizures Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Acute Repetitive Seizures Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Acute Repetitive Seizures Market Share by Regions: 2020 VS 2027
Figure 14. Global Acute Repetitive Seizures Market Share by Regions (2022-2027)
Figure 15. Global Acute Repetitive Seizures Market Share by Players in 2020
Figure 16. Global Top Acute Repetitive Seizures Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Repetitive Seizures as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Acute Repetitive Seizures Revenue in 2020
Figure 18. Global Acute Repetitive Seizures Revenue Market Share by Type (2016-2021)
Figure 19. Global Acute Repetitive Seizures Revenue Market Share by Type (2022-2027)
Figure 20. North America Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Acute Repetitive Seizures Market Share by Type (2016-2027)
Figure 22. North America Acute Repetitive Seizures Market Share by Application (2016-2027)
Figure 23. North America Acute Repetitive Seizures Market Share by Country (2016-2027)
Figure 24. United States Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Repetitive Seizures Market Share by Type (2016-2027)
Figure 28. Europe Acute Repetitive Seizures Market Share by Application (2016-2027)
Figure 29. Europe Acute Repetitive Seizures Market Share by Country (2016-2027)
Figure 30. Germany Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Repetitive Seizures Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Acute Repetitive Seizures Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Acute Repetitive Seizures Market Share by Region (2016-2027)
Figure 40. China Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Repetitive Seizures Market Share by Type (2016-2027)
Figure 48. Latin America Acute Repetitive Seizures Market Share by Application (2016-2027)
Figure 49. Latin America Acute Repetitive Seizures Market Share by Country (2016-2027)
Figure 50. Mexico Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Repetitive Seizures Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Acute Repetitive Seizures Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Acute Repetitive Seizures Market Share by Country (2016-2027)
Figure 56. Turkey Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Acute Repetitive Seizures Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UCB S.A. Revenue Growth Rate in Acute Repetitive Seizures Business (2016-2021)
Figure 60. Neurelis Revenue Growth Rate in Acute Repetitive Seizures Business (2016-2021)
Figure 61. Valeant Pharmaceuticals North America LLC. Revenue Growth Rate in Acute Repetitive Seizures Business (2016-2021)
Figure 62. Alexza Pharmaceuticals Revenue Growth Rate in Acute Repetitive Seizures Business (2016-2021)
Figure 63. Veriton Pharma Revenue Growth Rate in Acute Repetitive Seizures Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


【掲載企業】

UCB S.A.、Neurelis、Valeant Pharmaceuticals North America LLC.、Alexza Pharmaceuticals、Veriton Pharma

★調査レポート[世界の急性反復発作(ARS)市場規模・現状・予測2021-2027] (コード:QY21APR0078)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の急性反復発作(ARS)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆